FDA assigns PDUFA target action date of January 31, 2026 WARREN, N.J., June 16, 2025 (GLOBE NEWSWIRE) -- Aquestive Thera ...

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today ...

FDA assigns PDUFA target action date of January 31, 2026; WARREN, N.J., June (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Co ...

As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not ...

Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the ...

The manipulated video of Tiangco reporting on the alleged anti-aging serum was posted by a fake Facebook page posing as ...

Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the National Medical Products Administration (NMPA) ...

The concoction he made had a burgundy tinge, similar to a red wine, and a bubbly, cheery effervescence — hence the name that ...

Vitamin B12 gummies sold at ALDI and BJ's stores across the US have been recalled over an undeclared allergen.

Rakuten Medical, Inc., a global biotechnology company developing and commercializing Alluminox™ platform-based photoimmunotherapy, today announced that it was selected by the U.S. Food and Drug ...

(Reuters) -The U.S. Food and Drug Administration extended the review of KalVista Pharmaceuticals' drug for a type of ...